Survey on how safety information on medicines is included in clinical practice guidelines in the European Union
This survey is part of a research project led by Utrecht University with support from the European Medicines Agency (EMA), the Netherlands, with the aim to better understand how in your organisation new or updated safety information on medicines is used and prioritised to inform healthcare professionals and to update clinical practice guidelines in the medical field your organisation is responsible for.
Safety information on medicines includes for example warnings, contraindications, or patient monitoring requirements included in the product information or specific safety communications issued by regulatory authorities, for example EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) or national competent authorities in EU Member States responsible for assessing and monitoring the safety of human medicines.
This survey is available in all official EU languages (please select from drop-down list on introduction page), and no personal data is collected or processed.
Please follow the link to start the anonymous survey which takes 5 – 7 minutes to complete.
You may forward this email to other concerned colleagues in your organisation to populate the survey.
The survey is open until 30 June 2026.
Below you find your personalised link:
https://ec.europa.eu/eusurvey/